DART Study: Anti-TNF drug utilisation and dosing patterns assessment: a retrospective chart review study of subjects treated for RA

Trial Profile

DART Study: Anti-TNF drug utilisation and dosing patterns assessment: a retrospective chart review study of subjects treated for RA

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2008

At a glance

  • Drugs Adalimumab; Etanercept; Infliximab; Tumour necrosis factor inhibitors
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms DART
  • Most Recent Events

    • 22 Apr 2008 Results have been presented at British Society of Rheumatology's annual meeting in Liverpool, England.
    • 22 Apr 2008 Status changed from in progress to completed, according to information reported in a Wyeth media release.
    • 11 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top